RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 53 filers reported holding RECRO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,970 | -57.4% | 31,920 | 0.0% | 0.00% | – |
| Q2 2023 | $35,112 | -7.6% | 31,920 | 0.0% | 0.00% | – |
| Q1 2023 | $37,985 | +14126.6% | 31,920 | +17732.4% | 0.00% | – |
| Q4 2022 | $267 | -86.6% | 179 | -87.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 1,378 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 1,378 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 1,378 | -21.8% | 0.00% | – |
| Q4 2021 | $3,000 | +50.0% | 1,762 | +75.5% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 1,004 | +42.8% | 0.00% | – |
| Q2 2021 | $2,000 | -95.7% | 703 | -95.7% | 0.00% | – |
| Q1 2021 | $46,000 | +100.0% | 16,305 | +96.3% | 0.00% | – |
| Q4 2020 | $23,000 | +53.3% | 8,305 | +17.0% | 0.00% | – |
| Q3 2020 | $15,000 | -70.0% | 7,101 | -36.1% | 0.00% | – |
| Q2 2020 | $50,000 | -51.9% | 11,112 | -12.5% | 0.00% | – |
| Q1 2020 | $104,000 | -54.0% | 12,702 | +3.2% | 0.00% | – |
| Q4 2019 | $226,000 | +66.2% | 12,314 | -0.1% | 0.00% | – |
| Q3 2019 | $136,000 | -1.4% | 12,322 | -9.3% | 0.00% | – |
| Q2 2019 | $138,000 | +2.2% | 13,582 | -41.2% | 0.00% | – |
| Q1 2019 | $135,000 | -30.1% | 23,094 | -15.0% | 0.00% | – |
| Q4 2018 | $193,000 | +206.3% | 27,182 | +210.4% | 0.00% | – |
| Q3 2018 | $63,000 | +133.3% | 8,758 | +60.1% | 0.00% | – |
| Q2 2018 | $27,000 | +107.7% | 5,470 | +337.6% | 0.00% | – |
| Q1 2018 | $13,000 | -35.0% | 1,250 | -40.3% | 0.00% | – |
| Q4 2017 | $20,000 | -96.0% | 2,095 | -96.2% | 0.00% | – |
| Q3 2017 | $501,000 | +30.1% | 55,745 | +1.7% | 0.00% | – |
| Q2 2017 | $385,000 | +38400.0% | 54,835 | +43077.2% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 127 | +62.8% | 0.00% | – |
| Q4 2016 | $1,000 | – | 78 | +41.8% | 0.00% | – |
| Q2 2016 | $0 | – | 55 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |